DEA Archived Press Releases

Press Releases before January 20, 2025
702 Results - Showing 71 to 80
PRESS RELEASE

El Paso Fentanyl Dealer Sentenced to 20 Years in Federal Prison

EL PASO, Texas – An El Paso man was sentenced in a federal court in El Paso to 240 months in prison for distribution of a controlled substance causing serious bodily injury. According to court documents, Patrick Harley Chaires, 28, sold a counterfeit M-30 pill containing fentanyl on Jan. 10...
PRESS RELEASE

Drug Enforcement Administration Announces Fall Take Back Day

El Paso, Texas – On Saturday October 28, from 10 a.m. to 2 p.m., the Drug Enforcement Administration and various local agencies will host DEA’s National Prescription Drug Take Back Day at locations across the country. DEA and its partners will collect tablets, capsules, patches, and other solid forms of...
PRESS RELEASE

Man Sentenced in El Paso for Trafficking Meth into U.S. from Mexico

EL PASO, Texas – A Mexican national was sentenced in a federal court in El Paso to 70 months in prison for possession with intent to distribute 500 grams or more of a mixture or substance containing a detectable amount of methamphetamine. According to court documents, Cesar Tarango Cobos, 42...
PRESS RELEASE

DEA Holds Second Annual Family Summit on Fentanyl

WASHINGTON – On September 25 and 26, the U.S. Drug Enforcement Administration hosted the second annual DEA Family Summit on Fentanyl for families from across the country who have experienced the profound loss of a child due to a drug poisoning. U.S. Attorney General Merrick B. Garland and DEA Administrator...
PRESS RELEASE

Albuquerque Man Sentenced to 10 Years in Prison for Drug Trafficking and Federal Firearms Offenses

ALBUQUERQUE, N.M. – Eric Castañeda, Acting Special Agent in Charge of the Drug Enforcement Administration’s El Paso Division, and Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Leonardo Garcia was sentenced to 10 years in prison. Garcia, 39, of Albuquerque, pled guilty to...
PRESS RELEASE

Albuquerque Smoke Shop Owner Sentenced to 3 Years in Prison for Drug Offense

ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, and Raul Bujanda, Special Agent in Charge of the Federal Bureau of Investigation’s Albuquerque Field Office, announced today that Gabriel Monico Guevara was sentenced to 3 years in prison, a $10,000 fine, and $1,000 in...
PRESS RELEASE

Albuquerque Man Sentenced to 16 Years in Prison for Drug Trafficking and Federal Firearm Offenses

ALBUQUERQUE – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, and Eric Castañeda, Acting Special Agent in Charge of the Drug Enforcement Administration’s El Paso Division, announced today that Eloy Romero was sentenced to 195 months in prison. A federal jury returned a guilty verdict against...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

Albuquerque Man Sentenced to 10 Years for Drug Trafficking Offenses

ALBUQUERQUE, N.M. – Eric Castañeda, Acting Special Agent in Charge of the Drug Enforcement Administration’s El Paso Division, and Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Rafael Columbie was sentenced to 10 years in prison. A federal jury convicted Columbie, 54, of...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...